Log In
BCIQ
Print this Print this
 

VAL-1000

  Manage Alerts
Collapse Summary General Information
Company Senz Oncology Pty. Ltd.
DescriptionOral chemotherapeutic agent
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationAcute myelogenous leukemia (AML)
Indication DetailsTreat acute myelogenous leukemia (AML)
Regulatory Designation
PartnerAllyence Research Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today